An infant with HDFN can experience a number of symptoms, including lethargy, floppiness, excessive fatigue and irritability.

If your infant has been diagnosed with or shows signs of HDFN, consider keeping a journal to record their symptoms and ...

Transcutaneous bilirubinometry can reduce the pain and discomfort associated with assessments made via blood draws. Transcutaneous bilirubinometry is an effective, non-invasive alternative for ...

The updated RHAG system includes six antigens and one confirmed antithetical pair, and this may improve red blood cell ...

Donated blood is crucial to keeping blood supplies stable so that it can be used in saving the lives of fetuses and newborns ...

Early signs of hemolytic disease of the fetus and newborn (HDFN) can now be detected by 10 weeks, which could lead to better outcomes.

The summary describes the design of Johnson & Johnson's Phase 3 AZALEA trial, which will evaluate the efficacy of nipocalimab in HDFN.

Determining fetal RhD status early in RhD-negative pregnancies could help prevent the unnecessary administration of anti-D immunoglobulin.

A recent study found two patients with a novel mutation in the RHCE gene, which codes for several antigens found on red blood cells.